ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Mentice Showcases First-of-Its-Kind Flexible Coronary Training Solution at IMSH 2020
January 15, 2020The solution offers advanced functionality such as femoral and radial access, ability to remove stent and reset lesion for repeatable training, angle assistance to enhance 3D understanding, a large selection of anatomical variations including post CABG ca -
J&J announce first-of-its-kind portopulmonary hypertension study results
June 11, 2019Johnson & Johnson's Opsumit (macitentan) has shown significant improvement in pulmonary vascular resistance (PVR) in patients with portopulmonary hypertension (PoPH) after 24 weeks, in data published in The Lancet Respiratory Medicine.
Pharma Sources Insight January 2025
